Semnur Pharmaceuticals, Inc. (SMNR) Stock buybacks 2023–2024
Semnur Pharmaceuticals, Inc. (SMNR) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$43.4MFY2024 · since FY2023: $40.5M → $43.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $43.4M | +7.1% |
| FY2023 | $40.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SMNR financial trends
SMNR RevenueSMNR Net incomeSMNR Net marginSMNR Gross profitSMNR Gross marginSMNR Operating incomeSMNR Operating marginSMNR Operating cash flowSMNR Free cash flowSMNR Capital expendituresSMNR Return on equitySMNR Dividends paidSMNR Total assetsSMNR Total liabilitiesSMNR Shareholders’ equitySMNR overview →